Silexion Therapeutics Corp
SLXN$5.10B
Mid CapNASDAQBiological Products, (No Diagnostic Substances)🇺🇸North AmericaRAMAT GAN11 employees
Drugs in Pipeline
0
Phase 3 Programs
0
Upcoming Catalysts
0
Next Catalyst
None scheduled
Market Overview
Stock performance and key metrics
SLXN News
Catalyst Timeline
0 upcoming, 0 past
No catalysts found.
Drug Pipeline
No drugs found in this phase.
Regulatory Approvals
Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply